Case Study: Conatus Pharmaceuticals speeds global clinical trials with Veeva Systems' Vault eTMF and Vault QualityDocs

Conatus Pharmaceuticals Implements Veeva Vault eTMF and QualityDocs to Speed Global Clinical Trials of New Biologic Emricasan

Conatus Pharmaceuticals, a San Diego biotech developing the novel biologic emricasan, faced inefficient hybrid paper-and-electronic processes as it scaled global clinical trials and expanded collaboration with external partners and a largely mobile workforce. The company needed a paperless, industry-specific system to improve visibility, control, and collaboration while freeing staff from system maintenance so they could focus on R&D.

Conatus implemented Veeva Vault eTMF and Vault QualityDocs, a cloud-based, multitenant solution that provides a single authoritative source for trial and quality documents, DIA TMF–aligned structure, electronic signatures, and real-time reporting dashboards. The change eliminated paper copies, improved inspection readiness, sped information sharing across sites, reduced costs and system upkeep, and allowed teams to concentrate on core development activities.

Conatus

Steve Mento

CEO, Conatus